Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Exp Parasitol. 2011 Feb 19;128(2):170–175. doi: 10.1016/j.exppara.2011.02.016

Fig. 2.

Fig. 2

RWJ68198 and RWJ67657 are significantly more active against the chloroquine-resistant Plasmodium falciparum strain (W2) compared to the chloroquine-sensitive strain, HB3. Using the Sybr green I assay, the proliferation of strain HB3 (circles) was compared to strain W2 (squares) when treated with the indicated concentrations of p38 MAPK inhibitors. Dashed lines indicate the IC50 for each drug. Assays were replicated three times to obtain the mean and standard deviation IC50 values for each compound, with one representative experiment being shown.